David Zuckerman is president of Customized Improvement Strategies and is the author of "Pharmaceutical Metrics."
Big Pharma is finally making a commitment to partner-based outsourcing.
While execution quality doesn't deal with the protocol from a scientific standpoint, it is nonetheless critical to a successful outcome.
How Digital Medicine Can Pinpoint Dosing Regimens to Optimize Drug Efficacy and Safety
Sponsored By Oracle
Multi-faceted Approaches to Meet Payer and Regulatory Evidence Requirements
Sponsored By UBC Express Scripts
Overcoming the Life Sciences Content Conundrum in a Multichannel World
Sponsored By Veeva